423165-13-3

423165-13-3 structure

Name: 8-benzyl-3-exo-(3-isopropyl-5-methyl-4h-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane
Chemical Name: (1R,3s,5S)-8-Benzyl-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane
CAS Number: 423165-13-3
Molecular Formula: C₂₀H₂₈N₄
Molecular Weight: 324.463
Catalog: Pharmaceutical intermediate API intermediate
Create Date: 2018-10-21 18:36:10
Modify Date: 2025-08-26 21:34:48

Name	(1R,3s,5S)-8-Benzyl-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane
Synonyms	8-Azabicyclo[3.2.1]octane, 3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-(phenylmethyl)-, (3-exo) (3-exo)-8-Benzyl-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane 8-Benzyl-3-exo-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane

Density	1.2±0.1 g/cm3
Boiling Point	481.5±55.0 °C at 760 mmHg
Melting Point	149ºC
Molecular Formula	C₂₀H₂₈N₄
Molecular Weight	324.463
Flash Point	245.0±31.5 °C
Exact Mass	324.231384
PSA	33.95000
LogP	2.96
Vapour Pressure	0.0±1.2 mmHg at 25°C
Index of Refraction	1.649
Storage condition	2-8°C

HS Code	2933990090

376348-67-3

1068-57-1

~63%

423165-13-3

Literature: Auspex Pharmaceuticals, Inc. Patent: US2008/146605 A1, 2008 ; Location in patent: Page/Page column 41 ;

376348-67-3

6292-65-5

~74%

423165-13-3

Literature: Haycock-Lewandowski, Sarah J.; Wilder, Alexander; Ahman, Jens Organic Process Research and Development, 2008 , vol. 12, # 6 p. 1094 - 1103

76272-36-1

423165-13-3

Literature: Asano, Shigehiro; Gavrilyuk, Julia; Burton, Dennis R.; Barbas, Carlos F. ACS Medicinal Chemistry Letters, 2014 , vol. 5, # 2 p. 133 - 137

376348-67-3

423165-13-3

Literature: Asano, Shigehiro; Gavrilyuk, Julia; Burton, Dennis R.; Barbas, Carlos F. ACS Medicinal Chemistry Letters, 2014 , vol. 5, # 2 p. 133 - 137

76272-34-9

423165-13-3

Literature: SHANGHAI TARGETDRUG CO., LTD.; SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES Patent: US2011/251192 A1, 2011 ; US 20110251192 A1

132259-54-2

423165-13-3

Literature: Asano, Shigehiro; Gavrilyuk, Julia; Burton, Dennis R.; Barbas, Carlos F. ACS Medicinal Chemistry Letters, 2014 , vol. 5, # 2 p. 133 - 137

28957-72-4

423165-13-3

Literature: SHANGHAI TARGETDRUG CO., LTD.; SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES Patent: US2011/251192 A1, 2011 ; US 20110251192 A1

542-05-2

423165-13-3

Literature: SHANGHAI TARGETDRUG CO., LTD.; SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES Patent: US2011/251192 A1, 2011 ; US 20110251192 A1

100-46-9

423165-13-3

Literature: SHANGHAI TARGETDRUG CO., LTD.; SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES Patent: US2011/251192 A1, 2011 ; US 20110251192 A1

Precursor 9
376348-67-3 1068-57-1 6292-65-5 76272-36-1
76272-34-9 132259-54-2 28957-72-4 542-05-2
100-46-9
DownStream 4
423165-07-5 376348-70-8 376348-65-1 423165-08-6

HS Code	2933990090
Summary	2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

4472-84-8	1807940-52-8
1213357-58-4	1126423-40-2
1303426-70-1	1126424-58-5
740770-96-1	1303429-85-7
1083326-10-6	1367913-65-2